Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable?
For ondansetron, dexamethasone, and droperidol (when used for prophylaxis), each is estimated to reduce risk of postoperative nausea and/or vomiting (PONV) by approximately 25%. Current consensus guidelines denote that patients with 0–1 risk factors still have a 10–20% risk of encountering PONV, but...
Saved in:
Main Authors: | Susan J. Skledar, Brian A. Williams, Manuel C. Vallejo, Patricia L. Dalby, Jonathan H. Waters, Ronald Glick, Michael L. Kentor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2007.131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors affecting the implementation of guideline-based prophylactic antiemetic therapy for chemotherapy-induced nausea and vomiting in Japan: a protocol for a hospital-based qualitative study
by: Yosuke Uchitomi, et al.
Published: (2022-06-01) -
Aprepitant in a Multimodal Approach for Prevention of Postoperative Nausea and Vomiting in High-Risk Patients: Is There Such a Thing as “Too Many Modalities”?
by: John J. Hache, et al.
Published: (2009-01-01) -
The Lollipop with Lemon Aroma May Be Promising in Nausea and Vomiting in Pregnancy
by: Ismail Biyik, et al.
Published: (2020-03-01) -
Duodenum Inversum: A Rare Cause of Chronic Nausea and Vomiting
by: Saurabh Chandan, et al.
Published: (2018-01-01) -
Gambaran Skor INVR (Index of Nausea, Vomiting and Retching) pada CINV (Chemotherapy Induced Nausea and Vomiting) Kanker Payudara di RSUP M Djamil Padang
by: Wella Juartika, et al.
Published: (2020-01-01)